Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children

The Journal of Clinical Endocrinology and Metabolism
R CoutantJ L Chaussain

Abstract

Short term studies have demonstrated the acceleration of growth velocity after the administration of GH in short children born with intrauterine growth retardation (IUGR). We report the final heights of 70 IUGR children whose short stature was attributed to idiopathic GH deficiency (peak plasma GH <10 ng/mL at 2 provocative tests) and treated with GH at a mean dosage of 0.4 +/- 0.1 U/kg x week during an average of 4.6 +/- 2.5 yr. They were compared to a control group of 40 untreated short children born with IUGR, without GH deficiency. At the time of evaluation, age, auxological data, and pubertal status were similar in the 2 groups (height, -2.9 +/- 0.8 and -2.8 +/- 0.7 SD score). Final heights were comparable in both groups of children (-2 +/- 0.7 and -2.2 +/- 1.1 SD score). A multivariate analysis identified 4 independent predictors of final height, namely target height, age and body mass index at evaluation, and GH treatment. Treatment was associated with a gain of 0.6 SD score, suggesting a final height gain of about 3.4 cm. Fifty-three of 70 treated children were reevaluated after completion of growth, and 43 of 53 had a peak plasma GH level of 10 ng/mL or more. Auxological characteristics of these 53 patients were not di...Continue Reading

Citations

Jul 23, 2004·Archives of Disease in Childhood·L B Johnston, M O Savage
Mar 22, 2001·Archives of Disease in Childhood·S ZucchiniS Gualandi
Oct 16, 2012·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·M Güemes HidalgoJ Argente
Jun 10, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Dominique SimonJean-Claude Carel
Jan 22, 2008·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·T EdouardM Tauber
Jun 8, 2006·Molecular and Cellular Endocrinology·Lourdes Ibáñez, Francis de Zegher
Nov 4, 2005·Early Human Development·S Fang
May 18, 2016·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·José Manuel Rial RodríguezUNKNOWN en representación del Grupo de trabajo para el estudio del paciente pequeño para la edad gestacional (PEG) de la Sociedad Es
Dec 9, 2004·Pediatric Research·Jovanna DahlgrenUNKNOWN Swedish Study Group for Growth Hormone Treatment
Jan 5, 2000·Clinical Endocrinology·E CacciariS Gualandi
Oct 7, 2008·Advances in Therapy·Heike JungStenvert L S Drop
Mar 4, 2005·Treatments in Endocrinology·Roberto Lanes
Nov 3, 2005·Acta Paediatrica·Robert Rapaport, Torsten Tuvemo
Aug 10, 1999·Current Opinion in Pediatrics·D Botero, F Lifshitz
Sep 18, 2008·Arquivos brasileiros de endocrinologia e metabologia·Margaret C S Boguszewski, César Luiz Boguszewski
Mar 11, 2005·Indian Journal of Pediatrics·Anurag Bajpai, P Sn Menon
May 31, 2001·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·P GhirriA Boldrini
Jul 6, 2020·Journal of Pediatric Endocrinology & Metabolism : JPEM·José I LabartaLaura Sánchez-Cenizo
Jul 3, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Aruna Poduval, Paul Saenger
Aug 27, 2009·Pediatrics·Arianna Maiorana, Stefano Cianfarani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.